Environmental risk factors in multiple sclerosis

Objectives –  Multiple sclerosis (MS) likely results from an interaction between genetic and exogenous factors. While genetics shapes the overall population MS susceptibility, observed epidemiological patterns strongly suggest a role for the environment in disease initiation and modulation.

[1]  S. Mellgren,et al.  Multiple sclerosis in North Norway, and first appearance in an indigenous population , 2000, Journal of Neurology.

[2]  E. Thorsby,et al.  Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami. , 2007, Tissue antigens.

[3]  K. Myhr,et al.  Immunomodulatory treatment of multiple sclerosis in Norway , 2007, Acta neurologica Scandinavica. Supplementum.

[4]  K. Kyvik,et al.  Concordance for multiple sclerosis in Danish twins: an update of a nationwide study , 2005, Multiple sclerosis.

[5]  J. Lünemann,et al.  Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. , 2006, Brain : a journal of neurology.

[6]  M. Akiyama,et al.  A Positive Correlation between the Precursor Frequency of Cytotoxic Lymphocytes to Autologous Epstein‐Barr Virus‐Transformed B Cells and Antibody Titer Level against Epstein‐Barr Virus‐Associated Nuclear Antigen in Healthy Seropositive Individuals , 1993, Microbiology and immunology.

[7]  J. Dillner,et al.  An altered immune response to Epstein-Barr virus in multiple sclerosis , 2004, Neurology.

[8]  A. Svejgaard,et al.  HL-A antigens and multiple sclerosis. , 1972, Lancet.

[9]  T. Riise,et al.  Increasing Incidence of Multiple Sclerosis in the Province of Sassari, Northern Sardinia , 2005, Neuroepidemiology.

[10]  T. Riise,et al.  Evidence of early childhood as the susceptibility period in multiple sclerosis: space-time cluster analysis in a Sardinian population. , 2006, American journal of epidemiology.

[11]  C. Wolfson,et al.  The Latent Period of Multiple Sclerosis: A Critical Review , 1993, Epidemiology.

[12]  M. Cantorna,et al.  Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. , 2006, Progress in biophysics and molecular biology.

[13]  A. Sadovnick,et al.  A timing-of-birth effect on multiple sclerosis clinical phenotype , 2007, Neurology.

[14]  T. Christensen,et al.  A single subtype of Epstein–Barr virus in members of multiple sclerosis clusters , 1998, Acta neurologica Scandinavica.

[15]  M. Hernán,et al.  Cigarette smoking and the progression of multiple sclerosis. , 2005, Brain : a journal of neurology.

[16]  B. Weinshenker,et al.  Natural history of multiple sclerosis. , 2005, Neurologic clinics.

[17]  J. Kurtzke,et al.  On the Risk of Multiple Sclerosis According to Age at Immigration to South Africa* , 1971, British medical journal.

[18]  T. Wilsgaard,et al.  Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle , 2007, Journal of Neurology.

[19]  I. Ernberg,et al.  Molecular epidemiology of Epstein-Barr virus infection. , 1995, Advances in cancer research.

[20]  R. Jirtle,et al.  Environmental epigenomics and disease susceptibility , 2007, Nature Reviews Genetics.

[21]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part I: The role of infection , 2007, Annals of neurology.

[22]  A. Antonovsky,et al.  Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation. , 1966, Journal of neurology, neurosurgery, and psychiatry.

[23]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors , 2007, Annals of neurology.

[24]  A. Verma,et al.  Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study , 2008 .

[25]  H. Harbo,et al.  Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. , 2007, Nature genetics.

[26]  E. Norrby,et al.  Viral and bacterial antibody responses in multiple sclerosis , 1980, Annals of neurology.

[27]  S. Suissa,et al.  Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. , 2007, Brain : a journal of neurology.

[28]  M. Brustad,et al.  Vitamin D: A Candidate for the Environmental Effect in Multiple Sclerosis – Observations from Norway , 2008, Neuroepidemiology.

[29]  W. Valdar,et al.  Sex ratio of multiple sclerosis in Canada: a longitudinal study , 2006, The Lancet Neurology.

[30]  A. Mandavilli.  The sunshine cure. , 2007, Nature medicine.

[31]  D. Spiegelman,et al.  Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. , 2005, JAMA.

[32]  D. English,et al.  The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. , 2000, Brain : a journal of neurology.

[33]  T. Dwyer,et al.  Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study , 2003, BMJ : British Medical Journal.

[34]  Arne Svejgaard,et al.  A functional and structural basis for TCR cross-reactivity in multiple sclerosis , 2002, Nature Immunology.

[35]  P. Lantos,et al.  Thalamic degeneration with negative prion protein immunostaining , 2000, Journal of Neurology.

[36]  K. Myhr,et al.  The Norwegian Multiple Sclerosis National Competence Centre and National Multiple Sclerosis registry – a resource for clinical practice and research , 2006, Acta neurologica Scandinavica. Supplementum.

[37]  K. Büssow,et al.  Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. , 2005, The Journal of clinical investigation.

[38]  K. Rothman.  Induction and latent periods. , 1981, American journal of epidemiology.

[39]  A. Ascherio,et al.  Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysis , 2006, Annals of neurology.

[40]  J. Bach,et al.  The effect of infections on susceptibility to autoimmune and allergic diseases. , 2002, The New England journal of medicine.

[41]  S. Olindo,et al.  Role of return migration in the emergence of multiple sclerosis in the French West Indies. , 2005, Brain : a journal of neurology.

[42]  Silke Schmidt,et al.  Interleukin 7 receptor α chain ( IL7R ) shows allelic and functional association with multiple sclerosis , 2007, Nature Genetics.

[43]  H. Harbo,et al.  Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis , 2007, Nature Genetics.

[44]  R. Reynolds,et al.  Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain , 2007, The Journal of experimental medicine.

[45]  E. Barrett-Connor,et al.  Clustering of residence of multiple sclerosis patients at age 13 to 20 years in Hordaland, Norway. , 1991, American journal of epidemiology.

[46]  J. Aarseth,et al.  A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway , 2006, Neurology.

[47]  N. Raab-Traub,et al.  Compartmentalization and Transmission of Multiple Epstein-Barr Virus Strains in Asymptomatic Carriers , 2003, Journal of Virology.

[48]  R. Loewenson,et al.  Migration and risk of multiple sclerosis , 1978, Neurology.

[49]  G. Cutter,et al.  Infectious causes of multiple sclerosis , 2006, The Lancet Neurology.

[50]  D Spiegelman,et al.  Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. , 2001, JAMA.

[51]  A. Ascherio,et al.  Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. , 2006, Archives of neurology.

[52]  H. Link,et al.  Seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis , 2000, Journal of the Neurological Sciences.

[53]  P. Rothwell,et al.  Timing of birth and risk of multiple sclerosis: population based study , 2004, BMJ : British Medical Journal.

[54]  S. Gabriel,et al.  Risk alleles for multiple sclerosis identified by a genomewide study. , 2007, The New England journal of medicine.